This result was in line with the conclusion of a large prospective cohort study that failed to find any association of the ADRB1 rs1801253 and ADRB2 rs1042713 polymorphisms with mortality under an additive model in CAD patients (Cresci et al., 2012). Here, ADRB1 is linked to coronary artery disorder.